• FirefoxTry Yahoo Finance on Firefox »
  •  Dow Up 0.58% Nasdaq Up 0.26%

    Endocyte, Inc. (ECYT)

    -NasdaqGS
    3.06 Up 0.07(2.34%) 4:00PM EDT
    Prev Close:2.99
    Open:2.99
    Bid:2.90 x 500
    Ask:3.08 x 100
    1y Target Est:7.50
    Beta:1.16364
    Earnings Date:Nov 1 - Nov 7 (Est.)
    Day's Range:2.96 - 3.08
    52wk Range:2.65 - 5.70
    Volume:67,486
    Avg Vol (3m):145,597
    Market Cap:129.33M
    P/E (ttm):N/A
    EPS (ttm):-1.04
    Div & Yield:N/A (N/A)
    Quotes delayed, except where indicated otherwise. Currency in USD.

    Comparison

    Symbol% ChgMkt Cap
    ECYTUp 2.34%129.33M
    SNSSDown 4.35%76.57M
    NKTRDown 0.63%2.37B

    Key Statistics

    Forward P/E (1 yr):N/A
    P/S (ttm):1,805.23
    Ex-Dividend Date:N/A

    Analysts

    Annual EPS Est (Dec-16) :-1.12
    Quarterly EPS Est (Sep-16) :-0.27
    Mean Recommendation*:2.0
    PEG Ratio (5 yr expected):N/A

    * (Strong Buy) 1.0 - 5.0 (Sell)

    Analyst Opinion | Estimates

    Business Summary

    Endocyte, Inc., a biopharmaceutical company, develops targeted therapies for the treatment of cancer and inflammatory diseases in the United States. The company uses its technology to create novel small molecule drug conjugates (SMDCs) and compani... View More
    Your browser doesn't support canvas
    SETTINGS
    Scrolling
    Speed
    Display
    Price
    Submit Feedback